Dr. Bart Theodore Endrizzi, MD, PhD

Dr. Endrizzi practices at Associated Skin Care Specialists, PA in Saint Paul, Minnesota.

Dr. Endrizzi's NPI, 1235323585, was assigned on August 29, 2007. Dr. Endrizzi graduated from University of Minnesota Medical School in 2005. Dr. Endrizzi holds Minnesota license 52206.

Dr. Endrizzi's primary practice is Associated Skin Care Specialists, PA, at 119 14th NW St, Saint Paul, MN 55112 in Ramsey County. The practice phone is (763) 571-4000.

Dr. Endrizzi's primary practice is Associated Skin Care Specialists, PA in Saint Paul, Minnesota. The medical group on file is Associated Skin Care Specialists. Dmand AI also links Dr. Endrizzi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Endrizzi practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Endrizzi's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Endrizzi is licensed in Minnesota.

CMS data shows 1,805 Medicare services from Dr. Endrizzi across 20 procedure codes in 2024, for 528 Medicare patients. Medicare paid $422,531 for them. Every service was in an office.

CMS counts 528 Medicare patients who saw Dr. Endrizzi in 2024. The largest group is 75 to 84, with 226 patients. 70% of them have high blood pressure, and 69% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Endrizzi's median patient age at 69, with 50% women.

In 2024, Dr. Endrizzi wrote 499 Medicare Part D claims for 319 patients. 96% of them were for generic drugs. CMS names the drug for 440 of them, across 7 drugs with 11 or more claims each, at $7,085 in total drug cost. In 2023, CMS named 401 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Endrizzi for performance year 2024, reported as part of a group. Dr. Endrizzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 87 procedures of melanoma (skin cancer) excision by Dr. Endrizzi, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Endrizzi, published from 2010 to 2013. 2012 was the busiest year, with 2. The most frequent topics are Mohs Surgery and Skin Neoplasms. Dr. Endrizzi has published most often in Dermatol Surg. Dr. Endrizzi's most frequent co-authors are Brian David Zelickson, MD, James Theodore Dorrian, MD and Arkadiusz Zbigniew Dudek, MD.

CMS Open Payments shows 55 general payments to Dr. Endrizzi from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Genentech, Inc. paid the most, $108.

Dr. Endrizzi graduated from University of Minnesota Medical School in 2005.